IN2012DN00939A - - Google Patents

Info

Publication number
IN2012DN00939A
IN2012DN00939A IN939DEN2012A IN2012DN00939A IN 2012DN00939 A IN2012DN00939 A IN 2012DN00939A IN 939DEN2012 A IN939DEN2012 A IN 939DEN2012A IN 2012DN00939 A IN2012DN00939 A IN 2012DN00939A
Authority
IN
India
Prior art keywords
inhibitors
manufacture
quorum sensing
bacterial communication
bacterial
Prior art date
Application number
Other languages
English (en)
Inventor
M Meijler Michael
Amara Neri
Rayo Josep
Original Assignee
Nat Inst For Biotechnology In The Negev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst For Biotechnology In The Negev Ltd filed Critical Nat Inst For Biotechnology In The Negev Ltd
Publication of IN2012DN00939A publication Critical patent/IN2012DN00939A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/08—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN939DEN2012 2009-07-03 2010-07-04 IN2012DN00939A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22294409P 2009-07-03 2009-07-03
PCT/IB2010/053061 WO2011001419A1 (fr) 2009-07-03 2010-07-04 Inhibition par formation de liaison covalente, de la détection du quorum par des bactéries

Publications (1)

Publication Number Publication Date
IN2012DN00939A true IN2012DN00939A (fr) 2015-04-03

Family

ID=42711946

Family Applications (1)

Application Number Title Priority Date Filing Date
IN939DEN2012 IN2012DN00939A (fr) 2009-07-03 2010-07-04

Country Status (8)

Country Link
US (2) US8501969B2 (fr)
EP (1) EP2448930B1 (fr)
JP (1) JP5816618B2 (fr)
CN (1) CN102482244B (fr)
AU (1) AU2010267596A1 (fr)
CA (1) CA2767183C (fr)
IN (1) IN2012DN00939A (fr)
WO (1) WO2011001419A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
US8933119B2 (en) * 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10647668B2 (en) * 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9962361B2 (en) * 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en) * 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
CN102219753B (zh) * 2011-04-21 2012-10-31 山东大学 一种三氮唑类化合物及其制备方法与应用
EP2753177A1 (fr) * 2011-09-09 2014-07-16 Bayer Intellectual Property GmbH Dérivés lactones d'acylhomosérine pour l'amélioration du rendement de production de plantes
CN103980219B (zh) * 2013-02-08 2016-12-28 中国人民解放军军事医学科学院毒物药物研究所 一种新型细菌群体感应调节剂及其医疗用途
KR101819874B1 (ko) 2013-03-19 2018-01-17 더 스크립스 리서치 인스티튜트 암 세포를 선택적으로 죽이는 trail 강화제
US9751851B2 (en) 2013-09-20 2017-09-05 The Trustees Of Princeton University Molecules and compositions that inhibit gram negative bacteria and their uses
SG11201703588SA (en) * 2014-11-03 2017-05-30 Nicolai Vladimirovich Bovin Antimicrobial surface treatment
EP3285762A4 (fr) * 2015-04-23 2019-02-06 Dibrov, Pavel Dérivés de korormicine utiles en tant qu'antibiotiques
CN104909450B (zh) * 2015-06-01 2017-03-08 东北电力大学 一种膜生物反应器膜污染抑制剂的制备及其应用方法
CN106635446B (zh) * 2016-09-26 2019-08-13 浙江工商大学 一种生物膜清洁剂及其制备和应用
CN108130358A (zh) * 2017-12-21 2018-06-08 广西医科大学 对铜绿假单胞菌-烟曲霉菌混合生物被膜抑制作用的研究方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN109608292B (zh) * 2018-12-27 2021-11-30 中国科学院生态环境研究中心 一种氮肥组合物及其用途
FR3112343B1 (fr) * 2020-07-10 2022-12-23 Arkema France Procédé de fabrication d’acides et esters Ω-bromoalcanoïques
US20250136546A1 (en) * 2021-09-20 2025-05-01 3M Innovative Properties Company Thiol-based beta-diketone primers for adhesion to metal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007588D0 (en) * 2000-03-30 2000-05-17 Univ Nottingham N-Acyl homoserine lactones
US6703513B1 (en) * 2000-06-02 2004-03-09 K-Quay Enterprises Llc Production and use of derivatized homoserine lactones
GB0116312D0 (en) * 2001-07-04 2001-08-29 Univ Nottingham "Compositions containing N-acyl homoserine lactones"
GB0122026D0 (en) * 2001-09-12 2001-10-31 Univ Nottingham Insulitis
GB0122914D0 (en) 2001-09-22 2001-11-14 Univ Nottingham Modulation of stat activity
US7498292B2 (en) 2002-08-15 2009-03-03 The Research Foundation Of State University Of New York Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
AU2006210570B2 (en) * 2005-02-04 2012-09-06 Wisconsin Alumni Research Foundation Compounds and methods for modulating communication and virulence in quorum sensing bacteria

Also Published As

Publication number Publication date
US20120135925A1 (en) 2012-05-31
AU2010267596A1 (en) 2012-02-02
JP2012532095A (ja) 2012-12-13
EP2448930A1 (fr) 2012-05-09
CN102482244A (zh) 2012-05-30
CA2767183C (fr) 2018-03-13
US9242951B2 (en) 2016-01-26
US20140073690A1 (en) 2014-03-13
US8501969B2 (en) 2013-08-06
EP2448930B1 (fr) 2017-02-15
CN102482244B (zh) 2015-09-09
WO2011001419A1 (fr) 2011-01-06
CA2767183A1 (fr) 2011-01-06
JP5816618B2 (ja) 2015-11-18

Similar Documents

Publication Publication Date Title
IN2012DN00939A (fr)
EP2558582A4 (fr) Micro-organismes et procédés de production d'éthylène glycol
MY153116A (en) Smac mimetic
EP2435426B8 (fr) Benzoxazépines comme inhibiteurs de pi3k/m tor, méthodes d'utilisation et de fabrication
MY179933A (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereof
SG148142A1 (en) Aryloazol-2-yl cyanoethylamino compunds, method of making and method of using thereof
MX2012012827A (es) Microorganismos y metodos para la biosintesis de butadieno.
AP2011005913A0 (en) Inhibitors of beta-secretase.
MX336001B (es) Anticuerpos anti-axl y metodos de uso.
GB201004179D0 (en) Enzyme inhibitors
GB201004178D0 (en) Enzyme inhibitors
PL2658444T3 (pl) Sposób dostarczania wydajnego biosensora oraz odpowiedni biosensor, podłoże i zestaw do wprowadzania
EP2563926A4 (fr) Micro-organismes et méthodes de biosynthèse de propylène
MX2012011829A (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
MY161601A (en) Films and compositions comprising the same
MX393754B (es) Metodos y composiciones para inhibir cnksr1
EP2416661A4 (fr) Inhibiteurs du système de sécrétion de type iii bactérien
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
GB2475627A (en) Resource-availability system and method
ZA201204339B (en) Novel (heterocycle-tetrahydropyridine)(piperazinyl)-1-alcanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alcanone derivatives,and use thereof as p75 inhibitors
WO2011146624A9 (fr) Procédés de traitement d'une infection bactérienne récurrente
PT2306995E (pt) Propriedades antitumorais de inibidores de protease não modidficados
MX2012001875A (es) Proceso para la preparación de inhibidores de la catepsina s.
PH12012501547A1 (en) Methods of preparing thiazolidines
MY177531A (en) An arrangement for preventing landslide